Trial intelligence / Profile preview

Buscopan in IVF/ICSI prior to embryo transfer

NCT04751084Active, not recruiting

Sponsor
The Chinese University of Hong Kong
Start
May 2020
Primary completion
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in infertility comparing Buscopan Group with Placebo Group (2 arms). Primary endpoint: Live birth rate. Started May 2020; status: active, not recruiting.

02

Drugs

hyoscine butylbromide
03

Conditions

infertility

Beyond the preview

Go deeper on NCT04751084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04751084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call